U.S. Physical Therapy, Inc. (USPH) Position Boosted by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. lifted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 63.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 31,576 shares of the company’s stock after purchasing an additional 12,231 shares during the quarter. Goldman Sachs Group Inc. owned 0.25% of U.S. Physical Therapy worth $2,280,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its position in U.S. Physical Therapy by 2.5% during the 4th quarter. BlackRock Inc. now owns 1,621,087 shares of the company’s stock worth $117,043,000 after acquiring an additional 40,093 shares during the period. Dimensional Fund Advisors LP boosted its position in U.S. Physical Therapy by 1.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 493,972 shares of the company’s stock worth $30,355,000 after acquiring an additional 7,197 shares during the period. BTIM Corp. boosted its position in U.S. Physical Therapy by 0.7% during the 4th quarter. BTIM Corp. now owns 280,557 shares of the company’s stock worth $20,256,000 after acquiring an additional 1,952 shares during the period. Fred Alger Management Inc. boosted its position in U.S. Physical Therapy by 1.4% during the 4th quarter. Fred Alger Management Inc. now owns 237,609 shares of the company’s stock worth $17,155,000 after acquiring an additional 3,296 shares during the period. Finally, Copeland Capital Management LLC acquired a new stake in U.S. Physical Therapy during the 4th quarter worth about $12,459,000. Institutional investors and hedge funds own 96.56% of the company’s stock.

Shares of U.S. Physical Therapy stock opened at $87.05 on Monday. The stock has a market cap of $1,092.05, a PE ratio of 41.85, a PEG ratio of 3.17 and a beta of 1.08. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.95 and a quick ratio of 1.95. U.S. Physical Therapy, Inc. has a 52-week low of $56.50 and a 52-week high of $87.50.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, March 8th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.49. The business had revenue of $109.20 million during the quarter, compared to analyst estimates of $104.12 million. U.S. Physical Therapy had a return on equity of 13.12% and a net margin of 5.38%. equities analysts expect that U.S. Physical Therapy, Inc. will post 2.44 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, April 13th. Stockholders of record on Wednesday, March 21st were issued a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 1.06%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Tuesday, March 20th. U.S. Physical Therapy’s payout ratio is currently 44.23%.

In related news, Director Bernard A. Harris, Jr. sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $86.53, for a total value of $519,180.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Glenn Mcdowell sold 2,743 shares of the firm’s stock in a transaction that occurred on Tuesday, March 13th. The shares were sold at an average price of $86.11, for a total value of $236,199.73. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 18,643 shares of company stock valued at $1,583,645. 3.10% of the stock is owned by corporate insiders.

A number of equities research analysts have commented on the company. Cantor Fitzgerald restated a “buy” rating and set a $80.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, January 9th. Barrington Research restated a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, March 9th. Zacks Investment Research lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Friday, March 9th. Jefferies Group set a $76.00 price objective on U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, February 23rd. Finally, ValuEngine upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. U.S. Physical Therapy presently has an average rating of “Hold” and a consensus price target of $79.40.

COPYRIGHT VIOLATION NOTICE: “U.S. Physical Therapy, Inc. (USPH) Position Boosted by Goldman Sachs Group Inc.” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/04/16/u-s-physical-therapy-inc-usph-position-boosted-by-goldman-sachs-group-inc.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply